In a national television advertising campaign promoting FDA-approved Belviq (lorcaserin HCl) CIV, Eisai Inc. shows struggles people who are obese, or overweight with a comorbidity, commonly face in their efforts to lose or control weight.
The 2-minute commercial — airing on networks including Lifetime, Oxygen and AMC — promotes the drug as a targeted approach to weight loss and management when combined with a reduced-calorie diet and increased activity.
Full Story »
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.